GILD logo

Gilead Sciences (GILD) Company Overview

Profile

Full Name:

Gilead Sciences, Inc.

Sector:

Healthcare

Industry:

Drug Manufacturers - General

Country:

United States

IPO:

January 22, 1992

Indexes:

S&P 500,NASDAQ 100

Website:

http://www.gilead.com

Description:

Gilead Sciences, Inc. is an American research-based biopharmaceutical company founded in 1987 with headquarters in Foster City, California. The company is engaged in the search, development, and commercialization of innovative drugs for serious diseases such as HIV, AIDS, liver disease, hematology, oncology, and respiratory diseases. The company produces a wide range of products under its own brands, including AmBisome, Atripla, Biktarvy, Cayston, Complera, Descovy, Epclusa, Genvoya, Harvoni, Hepsera, Letairis, Odefsey, Ranexa, Sovaldi, Stribild, Tybost, Vemlidy, Vosevi, Yescarta, Zydelig, and others. The existing product portfolio is constantly being supplemented and expanded through the company's ongoing research and development, licensing, and strategic partnerships.

Key Details

Price

$117.49

Market Cap

$146.32 B(Mega cap)

Last Dividend

$0.77

TTM Dividend Yield

2.62%

Annual Revenue

$28.75 B(+6.04% YoY)

Annual EPS

$0.38(-91.56% YoY)

PE Ratio

317.54

Annual ROE

2.29%

Annual Debt To Equity

0.00

Beta

0.16

Events Calendar

Earnings

Next earnings date:

Apr 24, 2025

Recent quarterly earnings:

Feb 11, 2025

Recent annual earnings:

Feb 11, 2025
Dividend

Next ex-dividend date:

Mar 14, 2025

Recent ex-dividend date:

Dec 13, 2024
Splits

Next split:

N/A

Recent split:

Jan 28, 2013

Analyst ratings

Recent major analysts updates

Mar 5, 25 Wells Fargo
Overweight
Mar 5, 25 B of A Securities
Buy
Mar 4, 25 Oppenheimer
Outperform
Feb 18, 25 Deutsche Bank
Buy
Feb 12, 25 Wells Fargo
Overweight
Feb 12, 25 RBC Capital
Sector Perform
Feb 12, 25 Piper Sandler
Overweight
Feb 12, 25 Needham
Hold
Feb 12, 25 Morgan Stanley
Overweight
Feb 12, 25 Goldman Sachs
Neutral

Screeners with GILD included

Growing Shares Outstanding
US stocks
S&P 500 companies earnings calendar
NASDAQ 100 companies
Most recommended stocks
Best performing stocks last 3 months
Best performing stocks last 5 years
Stocks above SMA 50
S&P 500 companies
S&P 500 companies dividend calendar

Market Data

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Price

Current Price

$117.49
GILD price is $117.49

Price All-time High

$122.21
GILD price is currently -3.86% below its historical high of $122.21

Price Analysts Target

$108.00
GILD price is currently +8.79% higher than the consensus analysts' forecast

Price Most Recent Change

+1.5%
GILD price was up +1.5% on Mar 8, 2025

Price YTD Change

+27.15%
GILD price is up +27.15% since January 1st

Price 3-Year Change

+94.97%
GILD price is up +94.97% over the past 3 years

Market cap

Market Cap

$146.32 B
GILD market capitalization is $146.32 billion

Market Cap 3-Year Change

+93.72%
GILD market capitalization is up +93.72% over the past 3 years

Market Cap All-time High

$179.60 B
GILD market capitalization is currently -18.53% below its historical high of $179.60 billion

Market Cap Sector Rank

98.77%
GILD market capitalization is higher than 98.77% of companies in Healthcare sector

Technical

Beta

0.16
GILD beta is 0.16

200-day SMA

$84.56
GILD price is currently +38.94% above its 200-day simple moving average

14-day RSI

78.44
GILD 14-day relative strength index is 78.44

30-day Relative Volume

1.40
GILD 30-day relative volume is 1.40

Dividend

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Events

Last Paid Dividend

$0.77
GILD last dividend was $0.77 per share, with an ex-dividend date of December 13, 2024

Next Dividend

$0.79
GILD has announced a dividend of $0.79 per share, with an ex-dividend date set for March 14, 2025

Dividend per share

Annual Dividend Per Share

$3.08
GILD annual dividend per share is $3.08

Annual Dividend Per Share Sector Rank

85.54%
GILD annual dividend per share is higher than 85.54% of companies in Healthcare sector

Annual Dividend Per Share 1-Year Change

+2.67%
GILD annual dividend per share is up +2.67% year-on-year

Annual Dividend Per Share 3-Year Change

+8.45%
GILD annual dividend per share is up +8.45% over the past 3 years

Dividend yield

Annual Dividend Yield

2.62%
GILD annual dividend yield is 2.62%

Annual Dividend Yield Sector Rank

59.76%
GILD annual dividend yield is higher than 59.76% of companies in Healthcare sector

Other

Annual Payout Ratio

-
GILD annual payout ratio value is unknown

Annual Dividends Paid

-
GILD annual dividends paid value is unknown

Annual FCF

$10.83 B
GILD annual free cash flow is $10.83 billion

Profitability

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Annual Revenue

$28.75 B
GILD annual revenue is $28.75 billion

Annual Revenue Analysts Estimate

$28.65 B
GILD annual revenue is currently +0.38% higher than the consensus analysts' forecast

Annual Revenue 1-Year Change

+6.04%
GILD annual revenue is up +6.04% year-on-year

Annual Revenue Sector Rank

96.96%
GILD annual revenue is higher than 96.96% of companies in Healthcare sector

Profit

Annual Gross Profit

$22.50 B
GILD annual gross profit is $22.50 billion

Annual Gross Margin

78.26%
GILD annual gross profit margin is 78.26%

Annual Operating Profit

$10.51 B
GILD annual operating income is $10.51 billion

Annual Operating Margin

36.53%
GILD annual operating profit margin is 36.53%

Annual Net Income

$480.00 M
GILD annual net profit is $480.00 million

Annual Net Margin

1.67%
GILD annual net profit margin is 1.67%

EPS

Annual EPS

$0.38
GILD annual earnings per share is $0.38

Annual EPS Analysts Estimate

$7.94
GILD annual earnings per share is currently -95.22% lower than the consensus analysts' forecast

Annual EPS 1-Year Change

-91.56%
GILD annual earnings per share is down -91.56% year-on-year

Annual EPS Sector Rank

85.59%
GILD annual earnings per share is higher than 85.59% of companies in Healthcare sector

ROA & ROE

Annual ROA

0.79%
GILD annual return on assets is 0.79%

Annual ROE

2.29%
GILD annual return on equity is 2.29%

EBIT & EBITDA

Annual EBIT

$1.67 B
GILD annual earnings before interest & taxes is $1.67 billion

Annual EBITDA

$1.67 B
GILD annual EBITDA is $1.67 billion

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PE Ratio

317.54
GILD price to earnings ratio is 317.54

PE Ratio Sector Rank

97.04%
GILD price to earnings ratio is higher than 97.04% of companies in Healthcare sector

PB Ratio

PB Ratio

7.57
GILD price to book ratio is 7.57

PB Ratio Sector Rank

88.63%
GILD price to book ratio is higher than 88.63% of companies in Healthcare sector

PS Ratio

PS Ratio

5.09
GILD price to sales ratio is 5.09

PS Ratio Sector Rank

64.15%
GILD price to sales ratio is higher than 64.15% of companies in Healthcare sector

Enterprise value

Enterprise Value

$163.04 B
GILD enterprise value is $163.04 billion

Enterprise Value Sector Rank

98.84%
GILD enterprise value is higher than 98.84% of companies in Healthcare sector

EV/EBITDA

EV/EBITDA

43.57
GILD EV/EBITDA is 43.57

EV/EBITDA Sector Rank

96.06%
GILD EV/EBITDA is higher than 96.06% of companies in Healthcare sector

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Annual Current Ratio

1.50
GILD annual current ratio is 1.50

Annual Quick Ratio

1.20
GILD annual quick ratio is 1.20

Leverage

Annual Debt To Equity

0.00
GILD annual debt to equity ratio is 0.00

Annual Interest Coverage Ratio

1.71
GILD annual interest coverage ratio is 1.71

Risk & Stability

Piotroski F-Score

7
GILD piotroski f-score is 7

Altman Z-Score

-
GILD altman z-score value is unknown

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Annual Total Assets

$58.99 B
GILD annual total assets is $58.99 billion

Annual Non Current Assets

$40.99 B
GILD annual long term assets is $40.99 billion

Annual Current Assets

$18.00 B
GILD annual total current assets is $18.00 billion

Annual Cash & Cash Equivalents

-
GILD annual cash & cash equivalents value is unknown

Equity

Annual Book Value

$19.25 B
GILD annual book value is $19.25 billion

Annual Working Capital

$6.00 B
GILD annual working capital is $6.00 billion

Liabilities

Annual Total Liabilities

$39.75 B
GILD annual total liabilities is $39.75 billion

Annual Total Long Term Liabilities

$27.75 B
GILD annual total long term liabilities is $27.75 billion

Annual Current Liabilities

$12.00 B
GILD annual total current liabilities is $12.00 billion

Annual Accounts Payable

-
GILD annual accounts payable value is unknown

Debt

Annual Total Debt

$0.00
GILD annual total debt is $0.00

Annual Total Debt 1-Year Change

-100%
GILD annual total debt is down -100% year-on-year

Annual Long Term Debt

-
GILD annual long term debt value is unknown

Annual Short Term Debt

-
GILD annual short term debt value is unknown

Expenses

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Annual Total Expenses

$18.25 B
GILD annual total expenses is $18.25 billion

Annual Operating Expenses

$12.00 B
GILD annual total operating expenses is $12.00 billion

Annual Cost Of Goods Sold

$6.25 B
GILD annual cost of goods sold is $6.25 billion

Annual SGA

$6.09 B
GILD annual SGA is $6.09 billion

Annual D&A

-
GILD annual depreciation & amortization value is unknown

Annual Interest Expense

$977.00 M
GILD annual interest expense is $977.00 million

Cash Flow

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Annual CFO

$10.83 B
GILD annual cash flow from operations is $10.83 billion

Annual CFO 1-Year Change

+35.25%
GILD annual cash flow from operations is up +35.25% year-on-year

Annual CFI

-$3.45 B
GILD annual cash flow from investing activities is -$3.45 billion

Annual CFI 1-Year Change

-52.27%
GILD annual cash flow from investing activities is down -52.27% year-on-year

Annual CFF

-$3.43 B
GILD annual cash flow from financing activities is -$3.43 billion

Annual CFF 1-Year Change

+33.01%
GILD annual cash flow from financing activities is up +33.01% year-on-year

Free CashFlow

Annual FCF

$10.83 B
GILD annual free cash flow is $10.83 billion

Annual FCF 1-Year Change

+45.91%
GILD annual free cash flow is up +45.91% year-on-year

CAPEX

Annual CAPEX

-
GILD annual capital expenditures value is unknown

Annual CAPEX 1-Year Change

-
GILD annual capital expenditures 1-year change is unknown

Institutional Ownership

Similar stocks

SNY logo
Sanofi (SNY)
SYK logo
Stryker (SYK)
BSX logo
Boston Scientific (BSX)
PFE logo
Pfizer (PFE)
DHR logo
Danaher (DHR)
VRTX logo
Vertex Pharmaceuticals Incorporated (VRTX)
BMY logo
Bristol-Myers Squibb (BMY)
MDT logo
Medtronic (MDT)
AMGN logo
Amgen (AMGN)

FAQ

  • What is the ticker symbol for Gilead Sciences?
  • Does Gilead Sciences pay dividends?
  • What sector is Gilead Sciences in?
  • What industry is Gilead Sciences in?
  • What country is Gilead Sciences based in?
  • When did Gilead Sciences go public?
  • Is Gilead Sciences in the S&P 500?
  • Is Gilead Sciences in the NASDAQ 100?
  • Is Gilead Sciences in the Dow Jones?
  • When was Gilead Sciences's last earnings report?
  • When does Gilead Sciences report earnings?
  • Should I buy Gilead Sciences stock now?

What is the ticker symbol for Gilead Sciences?

The ticker symbol for Gilead Sciences is NASDAQ:GILD

Does Gilead Sciences pay dividends?

Yes, Gilead Sciences pays dividends. The last payment was $0.77, with an ex-dividend date on December 13, 2024

What sector is Gilead Sciences in?

Gilead Sciences is in the Healthcare sector

What industry is Gilead Sciences in?

Gilead Sciences is in the Drug Manufacturers - General industry

What country is Gilead Sciences based in?

Gilead Sciences is headquartered in United States

When did Gilead Sciences go public?

Gilead Sciences's initial public offering (IPO) was on January 22, 1992

Is Gilead Sciences in the S&P 500?

Yes, Gilead Sciences is included in the S&P 500 index

Is Gilead Sciences in the NASDAQ 100?

Yes, Gilead Sciences is included in the NASDAQ 100 index

Is Gilead Sciences in the Dow Jones?

No, Gilead Sciences is not included in the Dow Jones index

When was Gilead Sciences's last earnings report?

Gilead Sciences's most recent earnings report was on Feb 11, 2025

When does Gilead Sciences report earnings?

The next expected earnings date for Gilead Sciences is Apr 24, 2025

Should I buy Gilead Sciences stock now?

As of today, analysts generally recommend a 'Buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions